Amyloid-beta Aggregate Determination Assay Service
By detecting the various stages of amyloid-beta (Aβ) aggregates, researchers can more accurately assess the efficacy of potential therapeutic interventions and identify significant biomarkers for the development of novel drugs. For further information regarding the products and services provided, project-specific consultation, and pricing, please submit an inquiry here.
Introduction
Aβ aggregates are a key pathological feature of neurodegenerative diseases such as Alzheimer's disease (AD). Studies have shown that Aβ peptides accumulate in the brain and form fibrillar aggregates that are toxic to neurons, leading to cognitive impairment and dementia. Accurate detection and analysis of Aβ aggregates is therefore critical to understanding their role in the disease.
Available Assays at Creative Biolabs
- Aggregated Aβ Assay
Aβ monomers can self-assemble into low-molecular-weight oligomers, further form high-molecular-weight fibrillar structures, and finally deposit as amyloid plaques. Aβ aggregation is a dynamic process involving two stages: nucleation and polymerization, in which stable seeds (such as fibril fragments) serve as polymerization templates to accelerate aggregation. Our Aβ aggregation service is suitable for a variety of samples, including brain homogenate, cerebrospinal fluid, in vitro aggregated Aβ, and various cell culture samples.
For downstream detection, we can provide thioflavin T (ThT) or enzyme-linked immunosorbent assay (ELISA) based assays to detect the kinetics of Aβ aggregation.
ThT Assay
ThT is a commonly used dye that can specifically bind to amyloid fibrils and assess the formation of Aβ aggregates by monitoring changes in fluorescence intensity.
Fig.1 ThT fluorescence intensity correlated linearly with amyloid fibril concentration.2, 5
ELISA Assay
ELISA is commonly used to detect Aβ40 and Aβ42 aggregates by using specific antibodies to detect and quantify Aβ aggregates.
Fig.2 Total and fibril levels of Aβ1-40 and Aβ1-42 were analyzed by ELISA.3, 5
- Mass Spectrometry Analysis
Mass spectrometry can be used to identify and quantify the peptide composition of Aβ aggregates, helping to understand their structural and functional properties. Liquid chromatography-mass spectrometry can be used to analyze the composition of Aβ oligomers and fibers.
Fig.3 Human AD brain soluble Aβ aggregates mass spectrometry.4, 5
The specific method selected depends on the purpose of the experiment, the type of sample, and the resolution required. A combination of methods can provide a more comprehensive understanding of the mechanism of Aβ aggregation and its role in neurodegenerative diseases. Our services have helped many scientific research institutions and pharmaceutical companies achieve significant research results. Please contact us and we will match you with the most suitable Ph.D. scientist to communicate with you about your research and accelerate your plan.
References
- Polanco, David, et al. "Characterisation of Amyloid Aggregation and Inhibition by Diffusion-Based Single-Molecule Fluorescence Techniques." Biophysica 2.4 (2022): 506-524.
- Xue, Christine, et al. "Thioflavin T as an amyloid dye: fibril quantification, optimal concentration and effect on aggregation." Royal Society open science 4.1 (2017): 160696.
- Sehlin, Dag, et al. "Large aggregates are the major soluble Aβ species in AD brain fractionated with density gradient ultracentrifugation." PloS one 7.2 (2012): e32014.
- Esparza, Thomas J., et al. "Soluble amyloid-beta aggregates from human Alzheimer's disease brains." Scientific reports 6.1 (2016): 38187.
- Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-Amyloid Beta 1-15 Antibody (NRP-0422-P867) (Cat#: NRP-0422-P867)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1686) (Cat#: NRP-0422-P1686)
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- iNeuMab™ Anti-GARP Antibody (NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Anti-EPHB2 Antibody (NRP-0422-P1220) (Cat#: NRP-0422-P1220)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3503) (Cat#: NRZP-1022-ZP3503)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Rat Olfactory Ensheathing Cells (Cat#: NRZP-1122-ZP162)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Rat Muller Cell (Cat#: NCL2110P040)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Mouse Microglia Cell Line BV-2, Immortalized (Cat#: NCL2110P153)
- Rat Microglia Cell Line HAPI, Immortalized (Cat#: NCL2110P015)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)